tiprankstipranks
Advertisement
Advertisement

LOVFF Stock Latest News

Cannara Biotech Sets Date for Q2 2026 Results as Haywood Securities Initiates Coverage
Company AnnouncementsCannara Biotech Sets Date for Q2 2026 Results as Haywood Securities Initiates Coverage
6d ago
Cannara Biotech Wins TSX Listing and TD Cowen Coverage
PremiumCompany Announcements
Cannara Biotech Wins TSX Listing and TD Cowen Coverage
2M ago
Cannara Biotech to Uplist Shares to Toronto Stock Exchange
PremiumCompany Announcements
Cannara Biotech to Uplist Shares to Toronto Stock Exchange
2M ago
Cannara Biotech graduates to TSX
PremiumThe Fly
Cannara Biotech graduates to TSX
2M ago
Cannara Biotech initiated with a Buy at TD Securities
PremiumThe Fly
Cannara Biotech initiated with a Buy at TD Securities
2M ago
Cannara Biotech Schedules Investor Webcast to Highlight Cannabis Operations
PremiumCompany AnnouncementsCannara Biotech Schedules Investor Webcast to Highlight Cannabis Operations
2M ago
Cannara Biotech Secures C$6.3 Million Premium Private Placement from Phoenician Capital
Premium
Company Announcements
Cannara Biotech Secures C$6.3 Million Premium Private Placement from Phoenician Capital
2M ago
Cannara Biotech prices 3M shares at C$2.10 in private placement
Premium
The Fly
Cannara Biotech prices 3M shares at C$2.10 in private placement
2M ago
Cannara Biotech Secures Conditional TSX Approval in Strategic Uplisting Move
PremiumCompany Announcements
Cannara Biotech Secures Conditional TSX Approval in Strategic Uplisting Move
2M ago
Cannara Biotech announces conditional approval to list on TSX
PremiumThe Fly
Cannara Biotech announces conditional approval to list on TSX
2M ago
Cannara Biotech Posts Record Q1 2026 Results and Expands Canadian Cannabis Market Share
PremiumCompany Announcements
Cannara Biotech Posts Record Q1 2026 Results and Expands Canadian Cannabis Market Share
3M ago
Cannara Biotech reports Q1 EPS C$0.01 vs. C$0.03 last year
PremiumThe Fly
Cannara Biotech reports Q1 EPS C$0.01 vs. C$0.03 last year
3M ago
Cannara Biotech Upgrades to OTCQX and Sets Dates for Q1 Results and Shareholder Meeting
PremiumCompany AnnouncementsCannara Biotech Upgrades to OTCQX and Sets Dates for Q1 Results and Shareholder Meeting
3M ago
Cannara Biotech achieves OTCQX qualification
Premium
The Fly
Cannara Biotech achieves OTCQX qualification
3M ago
OTC Markets welcomes Cannara Biotech to OTCQX
Premium
The Fly
OTC Markets welcomes Cannara Biotech to OTCQX
3M ago
Cannara Biotech Takes Top Market Share in Québec and Cleans Up Equity Compensation Plans
PremiumCompany Announcements
Cannara Biotech Takes Top Market Share in Québec and Cleans Up Equity Compensation Plans
3M ago
Cannara Biotech provides update on Quebec vape category launch
PremiumThe Fly
Cannara Biotech provides update on Quebec vape category launch
3M ago
Cannara Biotech Reports Record Fiscal Year 2025
PremiumCompany Announcements
Cannara Biotech Reports Record Fiscal Year 2025
5M ago
Cannara Biotech Achieves Record Fiscal 2025 Performance and Market Expansion
PremiumCompany Announcements
Cannara Biotech Achieves Record Fiscal 2025 Performance and Market Expansion
5M ago
Cannara Biotech reports FY25 EPS C$0.14 vs. C$0.07 last year
PremiumThe FlyCannara Biotech reports FY25 EPS C$0.14 vs. C$0.07 last year
5M ago
Cannara Biotech to Release Financial Results and Mourns Board Member’s Passing
Premium
Company Announcements
Cannara Biotech to Release Financial Results and Mourns Board Member’s Passing
5M ago
Cannara Biotech Expands U.S. Market Access and Strengthens Financial Position
Premium
Company Announcements
Cannara Biotech Expands U.S. Market Access and Strengthens Financial Position
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >